Estimated Burden of Cardiovascular Disease and Value-Based Price Range for Evolocumab in a High-Risk, Secondary-Prevention Population in the US Payer Context

Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2017.1284078
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Informa UK Limited